ClinicalTrials.gg

Seizures clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 766 studies for Seizures across more than 10 countries. 134 are recruiting or about to start. 262 of them are mainly about Seizures (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-16. Counting its 3 narrower conditions too, such as Status Epilepticus: 898 studies, 166 open.

ClinicalTrials.gov finds 1,472 studies for Seizures. How that becomes 766 here

This page counts the studies the registry files under Seizures, and those it files under no condition that list Seizuresthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,472Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −126Filed under a narrower condition, counted on its own pageStatus Epilepticus 91 · Seizures, Febrile 20 · Psychogenic Nonepileptic Seizures 13
  3. −93List Seizures as a condition, but the registry did not file them under itMost often written as “Epilepsy; Seizure” (17), “Seizure Disorder” (10), and “Neonatal Seizure” (8). The registry filed 2 of them under no condition at all, and the others under other conditions only, most often Epilepsy (65) and Epilepsies, Partial (8).
  4. −487Match it another way305 name it in the title, 62 in a keyword, and 120 by a synonym or other text the search reads.
  5. 766The count on this page52 of them list Seizures in their own words; the registry filed them under no condition.

Status

Completed
445
Recruiting
92
Terminated
75
Status unknown
58
Not yet recruiting
30
Withdrawn
27

Phase

Phase 3
171
Phase 2
125
Phase 4
66
Phase 1
44
Early Phase 1
7

Where

United States
395
France
80
Spain
70
Germany
68
Italy
63
United Kingdom
62

Who develops what

Add Seizures to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 11 programs from 9 companies, 7 with this as their studies’ main aim; 4 with a live phase 3 study; 5 primary completions in the next 12 months. Compare H. Lundbeck, Jazz Pharmaceuticals and Sun Pharmaceutical Industries here →

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

DrugLeading trial sponsor · rightsCompanies, last 5 years
TopiramateEarlier only
Evidence
  • NCT01229735 · UCB S.A. · Phase 4 · comparator · “Topiramate” · registered Oct 2010
  • NCT00563459 · SK Biopharmaceuticals · Phase 3 · comparator · “topiramate” · registered Nov 2007
Johnson & Johnson68% of its industry studiesUS: off-patent, 29 generics marketed00 studies

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

In phase 3Company
bexicaserin☆ Track3 live phase-3 studies: NCT06660394, NCT06908226, NCT06719141H. Lundbeck A/S
RAP-219☆ Track2 live phase-3 studies: NCT07594119, NCT07563881Rapport Therapeutics Inc.

The 2 in phase 3 with the nearest primary completion, of 11 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (5)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

  • Dec 2026 est.elsunersen · Praxis Precision Medicines · Phase 3 registry mapping onlyNCT07019922 A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety — primary endpoint: To assess the efficacy of elsunersen on seizure frequency in participants with early-onset SCN2A DEE · 40 enrolled
  • 31 Dec 2026 est.bexicaserin · H. Lundbeck A/S · Phase 3 named, not the main aimNCT06660394 A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) — primary endpoint: Frequency Percent Change in Countable Motor Seizures During Treatment Compared to Baseline · 108 enrolled
  • Aug 2027 est.SPN-817 · Supernus Pharmaceuticals, Inc. · Phase 2 main aimNCT06798896 RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures — primary endpoint: Percent change (PCH) from baseline in focal onset seizure frequency per 28 days over the Maintenance Period · 216 enrolled

2 more — sign in to see them all, free.

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Seizures studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here Stimulants 2 open · Serotonin receptor agonists 1 open · Anxiolytics 16 · SSRIs 8

Coming up

54studies finish main data collection within a year11 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 92 Seizures studies recruiting now, 35 (38%) set no upper age limit and 44 (48%) stop at 75 or younger. 38 (41%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 18 (20%) take healthy volunteers.

Recruiting studies that take each age, of 92
AgeWomenMen
1026 (28%)26 (28%)
1877 (84%)77 (84%)
3074 (80%)74 (80%)
4075 (82%)75 (82%)
5075 (82%)75 (82%)
6568 (74%)68 (74%)
7557 (62%)57 (62%)
8546 (50%)46 (50%)

Across all 766 studies, recruiting or not: 51% stop at 75 or younger and 41% at 65; 53% take children; 2% are for women only and 1% for men only; 10% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Seizures studies take

Of 51 phase 3 interventional studies under Seizures, half reached primary completion within 54 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 136 mo26–56 · 16 studies——
Phase 240 mo20–58 · 35 studies——
Phase 354 mo33–79 · 51 studies54 mo33–79 · 43 studies—
Phase 428 mo20–42 · 26 studies——
Interventional, no phase32 mo22–51 · 83 studies—33 mo22–53 · 74 studies
Observational37 mo18–96 · 80 studies28 mo18–38 · 27 studies70 mo18–… · 53 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 766. Browse all 766 → or search them.